DAWN today

$21.53+$0.04 (+0.19%)close Apr 22, 2026

Trend

—

Key levels

Resistance$22.04

Resistance$21.58

Support$21.42

Support$21.30

Latest news & SEC filings

No headlines in the last 90 days.

· Healthcare

Day One Biopharmaceuticals, Inc. (DAWN)

$21.53+0.04 (+0.19%)
WATCHLISTGrade: C+Risk: MEDIUM
1D5D1M1Y5YMaxSign up for all timeframes
21.3121.3621.4221.4721.53Mar 19Mar 27Apr 7Apr 15
High21.53
Low21.49
Open21.50
Volume2.65M
Avg Vol2.54M
VWAP21.52
30d High21.53
30d Low21.25
30d Chg+1.32%
See full chart with real-time data

What Is the Price Target for DAWN?

SEPT Low Target

$0.00

SEPT Mid Target

$0.00

SEPT High Target

$0.00

Analyst Consensus

$0.00

Current: $21.53Upside: +0.0%Confidence: 20%Method: No Coverage

Is DAWN a Buy or Sell Right Now?

47
Investability Score
WATCHLIST12-18 months

Thesis

  • •Revenue growing 20.6% YoY with UNKNOWN trend — consistent growth.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for DAWN.

Start Free Trial →

Is DAWN Overvalued or Undervalued?

Valuation Verdict

FAIR

Methods Used

P/B

Fair Value

$21.40

17

Moat Score

NONE

4/9

Piotroski Score

18.6

Altman Z-Score

What Is Smart Money Doing with DAWN?

Insider Signal

SELLING

0 buys / 5 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

DISTRIBUTING

Short Squeeze Risk

HIGH

Signal: HIGH_SHORT_INTEREST

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

DAWN Growth Story

Revenue YoY

20.6%

3yr Revenue CAGR

N/A%

EPS Growth YoY

-1.96%

FCF Growth YoY

-29.6%

Revenue Trend

UNKNOWN

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for Day One Biopharmaceuticals, Inc. (DAWN) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

Sign Up Free — Download AI Report PDF →

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

Compare SEPT with other platforms

SEPT vs TradingViewSEPT vs BloombergSEPT vs Unusual WhalesSEPT vs SpotGammaSEPT vs TrendSpiderAI Trading Platforms Compared
What is dark pool trading?How to read options flowGEX explainedSmart money trackingAI stock analysisEarn money on SEPT

About SEPT Investing

SEPT Investing tracks 13,000+ stocks with live charts, trend and key-level tracking, dark pool and options flow, insider and congress trades, SEC filings and news alerts.

Disclaimer: This page is for informational purposes only. It does not constitute financial advice. Past performance does not guarantee future results. Always do your own research before making investment decisions.

DAWN — frequently asked questions

What is DAWN stock price today?

Day One Biopharmaceuticals, Inc. (DAWN) is at $21.53, up 0.19% (+$0.04) at the Apr 22, 2026 close.

Did DAWN beat earnings?

DAWN last reported on May 5, 2026: EPS -$0.35 vs -$0.31 expected — a miss of 12.9%.

Does DAWN pay a dividend?

DAWN does not currently pay a dividend.

What are DAWN support and resistance levels?

Support: $21.42, $21.30, $21.24. Resistance: $21.58, $22.04, $22.47.

What are insiders doing with DAWN?

Insider activity: SELLING, 0 buys and 5 sells in the last 90 days.